StonvexLoading…
StonvexCore line items from GTLB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | $955.22M | $759.25M | $579.91M | $424.34M |
Operating Income | $-70.48M | $-142.72M | $-187.44M | $-211.41M |
Net Income | $-55.96M | $-6.33M | $-425.68M | $-173.41M |
EPS (Diluted) | $-0.34 | $-0.04 | $-2.76 | $-1.17 |
Total Assets | $1.72B | $1.40B | $1.32B | $1.17B |
Total Liabilities | $686.50M | $577.96M | $715.01M | $344.48M |
Cash & Equivalents | $229.58M | $227.65M | $288.00M | $295.40M |
Free Cash Flow OCF − CapEx | $222.03M | $-67.74M | $33.44M | $-83.48M |
Shares Outstanding | 166.79M | 160.58M | 154.28M | 148.41M |